UW Virology Newsletter

April, 2024

As we transition into the warmer spring months and embrace the opportunity to spend more time outdoors enjoying the blossoming flowers and rejuvenating sunshine, it is common to observe a decline in the prevalence of both Influenza virus and Respiratory Syncytial Virus (RSV) circulating within our community. This seasonal shift, often accompanied by increased ventilation and reduced close contact indoors, contributes to a natural decrease in the transmission of these respiratory viruses, offering a welcome reprieve to many individuals only to be replaced with the challenge of pollen allergies.

The volume of SARS-CoV-2 virus testing has remained consistent at approximately 300 tests per day throughout March, with a positivity rate ranging between 3% and 5%. See www.cdc.gov/coronavirus/2019-ncov for the most recent updates.

Ordering information available here: https://depts.washington.edu/uwviro/.

View the UW Virology COVID-19 Dashboard.

Follow the area’s epidemiological data each week on the UW Virology web site at http://depts.washington.edu/uwviro/respiratory-viral-epidemiology-data/.

Community detections: March, 2024

PCR Positives:

Adenovirus – 22
BK Virus – 295
CMV – 303
Coronavirus – 24 (NOT 2019-nCoV)
EBV – 41
Enterovirus – 0
HHV6 – 24
HHV8 – 4
HSV – 83
Influenza A – 103

Influenza B – 17
JC Virus – 1
Metapneumovirus – 10
Monkeypox – 34
Parainfluenza – 10
Parechovirus – 0
Parvo B19 – 1
Rhinovirus – 33
RSV – 30
VZV – 35